Vitamin d drug may ease chronic pancreatitis pain
NCT ID NCT05664880
First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 3 times
Summary
This early-phase trial tests whether paricalcitol, a vitamin D analog, can improve quality of life in adults with chronic pancreatitis. Researchers will enroll 24 participants to take either the drug or a placebo for 12 months. The main goal is to see if the study is feasible and acceptable to patients, while also tracking pain and daily function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Paricalcitol (a vitamin D analog)
- What this could lead to
- If it works, this could point toward a new way to ease pain and improve daily life for people with chronic pancreatitis.
- What could go wrong
- This is a very early, small pilot study with only 24 people. It mainly checks if the idea is feasible, not if it truly works. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood and gut clues may flag pancreatic cancer risk early
- Can a lung drug tame the pain of chronic pancreatitis?
- Can a Decades-Old drug reverse pancreatic scarring?
- Can we predict who will develop pancreatic cancer from chronic pancreatitis?
- Brain scans reveal hidden pain pathways in chronic pancreatitis
- New device aims to make pancreatic and bile duct procedures safer